InVivoMAb anti-mouse CD122 (IL-2Rbeta)

Sultan H, Kumai T, Fesenkova VI, et al. Sustained Persistence of IL2 Signaling Enhances the Antitumor Effect of Peptide Vaccines through T-cell Expansion and Preventing PD-1 Inhibition. Cancer Immunol Res. 2018,6(5):617-627. doi: 10.1158/2326-6066.CIR-17-0549

Ohs I, van den Broek M, Nussbaum K, et al. Interleukin-12 bypasses common gamma-chain signalling in emergency natural killer cell lymphopoiesis. Nat Commun. 2016,7:13708. doi: 10.1038/ncomms13708

Brauner H, Hall HT, Flodström-Tullberg M, et al. Depletion of IL-2 receptor β-positive cells protects from diabetes in non-obese diabetic mice. Immunol Cell Biol. 2016,94(2):177-84. doi: 10.1038/icb.2015.78

Leung KT, Chan KY, Ng PC, et al. The tetraspanin CD9 regulates migration, adhesion, and homing of human cord blood CD34+ hematopoietic stem and progenitor cells. Blood. 2011,117(6):1840-50. doi: 10.1182/blood-2010-04-281329

Johansson SE, Hall H, Björklund J, et al. Broadly impaired NK cell function in non-obese diabetic mice is partially restored by NK cell activation in vivo and by IL-12/IL-18 in vitro. Int Immunol. 2004,16(1):1-11.

Tanaka T, Kitamura F, Nagasaka Y, et al. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice. J Exp Med. 1993,178(3):1103-7.

Tanaka T, Tsudo M, Karasuyama H, et al. A novel monoclonal antibody against murine IL-2 receptor beta-chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells. J Immunol. 1991,147(7):2222-8.